Neurocognitive effects of six ketamine infusions and the association with antidepressant effects in treatment-resistant bipolar depression: a preliminary study

PeerJ
Wei ZhengYu-Ping Ning

Abstract

The N-methyl-D-aspartate subtype glutamate receptor antagonist ketamine has rapid antidepressant and antisuicidal effects in treating treatment-resistant bipolar depression (TRBD). The neurocognitive effects of repeated ketamine infusions in TRBD are not known. Six intravenous infusions of ketamine (0.5 mg/kg over 40 min) were administered on a Monday-Wednesday-Friday schedule during a 12-day period on 16 patients with TRBD followed by a 2-week observational period. The assessment of neurocognitive function was conducted using the MATRICS Consensus Cognitive Battery at baseline, 13 and 26 days. Tasks were designed to test speed of processing, working memory, visual learning and verbal learning. A significant improvement was found only in scores of speed of processing (F = 9.9, p = 0.001) after a 2-week observational period, which was accounted for by the improvement of depression symptoms. There were no significant changes over time in terms of working memory, visual learning and verbal learning. Pearson correlation analysis showed that the improvement of depression symptoms through six ketamine infusions was greater among TRBD patients with lower working memory at baseline (r = 0.54, p = 0.03). In multiple regression analysis,...Continue Reading

References

Apr 1, 1979·The British Journal of Psychiatry : the Journal of Mental Science·S A Montgomery, M Asberg
Feb 1, 1988·Psychological Medicine·M M WeissmanL P Florio
Feb 1, 1960·Journal of Neurology, Neurosurgery, and Psychiatry·M HAMILTON
Nov 7, 2003·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Celia J A MorganH Valerie Curran
Nov 9, 2004·Schizophrenia Research·Michael F Green, Keith H Nuechterlein
Oct 13, 2005·Psychopharmacology·Arti ParwaniAdrienne C Lahti
Nov 11, 2006·Current Psychiatry Reports·Michael E Thase
Apr 27, 2007·Psychopharmacology·Edward B PerryUNKNOWN Yale Ketamine Study Group
Jan 4, 2008·The American Journal of Psychiatry·Keith H NuechterleinStephen R Marder
Aug 4, 2010·Archives of General Psychiatry·Nancy DiazgranadosCarlos A Zarate
Feb 23, 2013·Journal of Psychopharmacology·Keith G RasmussenMark A Frye
Jul 24, 2013·Brain Injury : [BI]·Lana J OzenMyra A Fernandes
Jan 11, 2014·Frontiers in Pharmacology·Caroline A Browne, Irwin Lucki
Mar 29, 2014·Handbook of Experimental Pharmacology·B LuY Lu
Jun 14, 2014·Molecular Diagnosis & Therapy·Monica Uddin
Jun 26, 2014·The International Journal of Neuropsychopharmacology·Paulo R ShiromaKelvin O Lim
Dec 4, 2014·CNS & Neurological Disorders Drug Targets·Beatrice BortolatoRoger S McIntyre
May 20, 2015·Journal of Affective Disorders·Corin BourneGuy M Goodwin
Dec 10, 2016·Frontiers in Behavioral Neuroscience·António MeloJosé M Pêgo
Jan 24, 2017·Biological Psychiatry·Joseph KambeitzNikolaos Koutsouleris
Mar 9, 2017·International Journal of Psychiatry in Clinical Practice·Janusz K RybakowskiAlicja Bartkowska-Sniatkowska
Oct 21, 2017·The British Journal of Psychiatry : the Journal of Mental Science·Paul RouxChristine Passerieux
Jun 5, 2018·Psychiatry Research·Xiaoyin KeNi Fan
Dec 28, 2018·Journal of Affective Disorders·Wei ZhengYu-Ping Ning
Jul 14, 2020·Journal of Affective Disorders·Wei ZhengYu-Ping Ning

❮ Previous
Next ❯

Software Mentioned

MATRICS
SPSS

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.